PMV Pharmaceuticals, Inc. (PMVP)

Latest Insider Confidence Score

2025Q4

48.1
Bearish

Company insider confidence (by quarter)

2020Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Orbimed Capital Llc 10% Owner 6,589,330 Mar 31, 2022
OrbiMed Genesis GP LLC 10% Owner 6,475,291 Nov 24, 2023
Orbimed Advisors Llc 10% Owner 4,975,291 Oct 27, 2025
OrbiMed Capital GP V LLC 10% Owner 4,975,291 Oct 27, 2025
Double Epiphany, LLC — 1,282,026 Sep 24, 2020

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 27, 2025 Oct 29, 2025 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Oct 23, 2025 Oct 27, 2025 ORBIMED ADVISORS LLC 10% Owner Sell 17.5 -1,000,000 -16.74% ✗ $1.5M
Sep 10, 2025 Sep 12, 2025 ORBIMED ADVISORS LLC 10% Owner Sell 20.0 -500,000 -7.72% ✗ $900K
Jul 1, 2025 Jul 3, 2025 Ticktin Robert COO Sell 26.3 -23,151 -19.00% ✗ $24.7K
Jul 1, 2025 Jul 3, 2025 Jalota Deepika Chief Development Officer Sell 26.3 -33,065 -26.88% ✗ $35.2K
Jul 1, 2025 Jul 3, 2025 Carulli Michael CFO Sell 26.3 -28,249 -31.96% ✗ $30.1K
Jul 1, 2025 Jul 3, 2025 Mack David Henry CEO Sell 22.5 -58,411 -6.05% ✗ $62.2K
Jun 5, 2025 Jun 9, 2025 Stelzer Laurie Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 LEVINE ARNOLD J Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Heyman Richard A. Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 Gallagher Carol Giltner Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 FLOWERS KIRSTEN Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 9, 2025 BAUM CHARLES M Director Neutral 52.5 - 0.00% ✗ -
Apr 23, 2025 Ticktin Robert COO Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 5, 2025 Carulli Michael CFO Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 5, 2025 Jalota Deepika Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 5, 2025 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Dec 3, 2024 Jan 22, 2025 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Aug 13, 2024 Oct 3, 2024 Jalota Deepika Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Aug 13, 2024 Oct 3, 2024 Carulli Michael CFO Neutral 52.5 - 0.00% ✗ -
Aug 13, 2024 Oct 3, 2024 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Sep 11, 2024 Sep 12, 2024 Jalota Deepika Chief Development Officer Sell 26.3 -7,218 -5.75% ✗ $10.9K
Sep 11, 2024 Sep 12, 2024 Carulli Michael CFO Sell 27.5 -2,891 -3.17% ✗ $4.3K
Jun 6, 2024 Jun 10, 2024 Stelzer Laurie Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 LEVINE ARNOLD J Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Heyman Richard A. Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Gallagher Carol Giltner Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 FLOWERS KIRSTEN Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 BAUM CHARLES M Director Neutral 52.5 - 0.00% ✗ -
Jan 18, 2024 Jan 22, 2024 Jalota Deepika Chief Development Officer Neutral 90.0 +95,555 319.09% ✗ -
Jan 18, 2024 Jan 22, 2024 Carulli Michael CFO Neutral 90.0 +82,220 906.90% ✗ -
Jan 18, 2024 Jan 22, 2024 Mack David Henry CEO Neutral 90.0 +163,890 25.26% ✗ -
Jan 11, 2024 Carulli Michael CFO Neutral 52.5 - 0.00% ✗ -
Nov 22, 2023 Nov 24, 2023 ORBIMED ADVISORS LLC 10% Owner Sell 22.5 -87,786 -100.00% ✗ $195.8K
Oct 18, 2023 Nov 13, 2023 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 18, 2023 Jalota Deepika Chief Development Officer Sell 26.3 -4,104 -12.05% ✗ $27.2K
Sep 15, 2023 Sep 18, 2023 Alland Leila Chief Medical Officer Sell 26.3 -6,291 -12.05% ✗ $41.6K
Aug 7, 2023 Aug 8, 2023 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Stelzer Laurie Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 LEVINE ARNOLD J Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Heyman Richard A. Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 Gallagher Carol Giltner Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 FLOWERS KIRSTEN Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 12, 2023 BAUM CHARLES M Director Neutral 52.5 - 0.00% ✗ -
May 12, 2023 May 15, 2023 Jalota Deepika Chief Development Officer Neutral 52.5 - 0.00% ✗ -
May 12, 2023 May 15, 2023 Alland Leila Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 12, 2023 May 15, 2023 Kung Winston CFO Neutral 52.5 - 0.00% ✗ -
May 12, 2023 May 15, 2023 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Nov 25, 2022 Jan 30, 2023 Kung Winston CFO Neutral 27.5 -2,560 -19.45% ✗ -
Nov 4, 2022 Nov 8, 2022 Gallagher Carol Giltner Director Neutral 52.5 - 0.00% ✗ -
Nov 8, 2022 Gallagher Carol Giltner Director Neutral 52.5 - 0.00% ✗ -
Sep 9, 2022 Sep 13, 2022 Jalota Deepika SVP, Regulatory Affairs and QA Neutral 90.0 +34,050 100.00% ✗ -
Sep 9, 2022 Sep 13, 2022 Alland Leila Chief Medical Officer Neutral 90.0 +52,200 100.00% ✗ -
Jun 2, 2022 Jun 6, 2022 Stelzer Laurie Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2022 Jun 6, 2022 LEVINE ARNOLD J Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2022 Jun 6, 2022 Heyman Richard A. Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2022 Jun 6, 2022 FLOWERS KIRSTEN Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2022 Jun 6, 2022 BAUM CHARLES M Director Neutral 52.5 - 0.00% ✗ -
May 26, 2022 May 31, 2022 ORBIMED ADVISORS LLC 10% Owner Sell 20.0 -26,253 -23.02% ✗ $418.2K
Apr 27, 2022 Apr 29, 2022 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Apr 20, 2022 Apr 21, 2022 Kung Winston CFO Neutral 52.5 - 0.00% ✗ -
Mar 29, 2022 Mar 31, 2022 ORBIMED ADVISORS LLC 10% Owner Sell 15.0 -474,500 -100.00% ✗ $10.3M
Mar 8, 2022 Mar 9, 2022 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2022 Feb 28, 2022 Jalota Deepika SVP, Regulatory Affairs and QA Neutral 52.5 - 0.00% ✗ -
Feb 10, 2022 Feb 28, 2022 Alland Leila Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 10, 2022 Feb 28, 2022 Kung Winston CFO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2022 Feb 28, 2022 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Dec 30, 2021 Feb 8, 2022 Kung Winston CFO Neutral 27.5 -2,725 -29.22% ✗ -
Jan 6, 2022 Jan 10, 2022 FLOWERS KIRSTEN Director Neutral 52.5 - 0.00% ✗ -
Jan 10, 2022 FLOWERS KIRSTEN Director Neutral 52.5 - 0.00% ✗ -
Dec 9, 2021 Dec 16, 2021 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Oct 6, 2021 Oct 8, 2021 Schroeder Thilo Director Sell 55.0 -800 -0.07% ✓ $24.1K
Sep 30, 2021 Oct 4, 2021 Schroeder Thilo Director Sell 42.5 -14,619 -1.31% ✓ $439.8K
Sep 27, 2021 Sep 29, 2021 Schroeder Thilo Director Sell 47.5 -7,461 -0.66% ✓ $224.3K
Sep 22, 2021 Sep 24, 2021 Schroeder Thilo Director Sell 58.8 -100 -0.01% ✓ $3K
Sep 22, 2021 Sep 23, 2021 LEVINE ARNOLD J Director Sell 47.5 -3,500 -0.85% ✓ $105K
Sep 17, 2021 Sep 21, 2021 Schroeder Thilo Director Sell 55.0 -711 -0.06% ✓ $21.4K
Sep 9, 2021 Sep 13, 2021 Schroeder Thilo Director Sell 27.5 -70,828 -5.92% ✓ $2.2M
Sep 9, 2021 Sep 10, 2021 Alland Leila Chief Medical Officer Sell 15.0 -100 -100.00% ✓ $3K
Sep 7, 2021 Sep 8, 2021 Alland Leila Chief Medical Officer Sell 10.0 -3,900 -100.00% ✓ $118K
Aug 31, 2021 Sep 2, 2021 Schroeder Thilo Director Sell 32.5 -46,906 -3.77% ✓ $1.4M
Aug 26, 2021 Aug 30, 2021 Schroeder Thilo Director Sell 32.5 -58,829 -4.52% ✓ $1.8M
Aug 23, 2021 Aug 25, 2021 Schroeder Thilo Director Sell 32.5 -51,854 -3.17% ✓ $1.6M
Aug 23, 2021 Aug 24, 2021 LEVINE ARNOLD J Director Sell 47.5 -3,500 -0.84% ✓ $103.3K
Aug 18, 2021 Aug 20, 2021 Schroeder Thilo Director Sell 40.0 -30,664 -1.84% ✓ $1M
Aug 19, 2021 Aug 20, 2021 Mack David Henry CEO Neutral 52.5 - 0.00% ✗ -
Aug 19, 2021 Aug 20, 2021 Kung Winston CFO Neutral 52.5 - 0.00% ✗ -
Aug 17, 2021 Aug 18, 2021 Jalota Deepika SVP, Regulatory Affairs and QA Sell 10.0 -2,896 -100.00% ✓ $97.8K
Aug 13, 2021 Aug 17, 2021 Schroeder Thilo Director Sell 32.5 -80,491 -4.60% ✓ $2.7M
Aug 10, 2021 Aug 12, 2021 Schroeder Thilo Director Sell 32.5 -68,480 -3.77% ✓ $2.4M
Aug 9, 2021 Aug 10, 2021 Alland Leila Chief Medical Officer Sell 10.0 -4,471 -68.82% ✓ $152.2K
Aug 5, 2021 Aug 9, 2021 Schroeder Thilo Director Sell 32.5 -77,693 -4.10% ✓ $2.8M
Aug 2, 2021 Aug 4, 2021 Schroeder Thilo Director Sell 32.5 -96,136 -4.83% ✓ $3.4M
Aug 3, 2021 Aug 4, 2021 Kung Winston CFO Sell 10.0 -4,500 -73.77% ✓ $152.2K
Jul 28, 2021 Jul 30, 2021 Schroeder Thilo Director Sell 45.0 -11,024 -0.55% ✓ $394.1K
Jul 23, 2021 Jul 27, 2021 Schroeder Thilo Director Sell 45.0 -17,362 -0.86% ✓ $623.5K
Jul 21, 2021 Jul 23, 2021 Schroeder Thilo Director Sell 45.0 -18,872 -0.93% ✓ $676K
May 12, 2021 Jul 23, 2021 Heyman Richard A. Director Neutral 52.5 - 0.00% ✗ -
Jul 20, 2021 Jul 22, 2021 LEVINE ARNOLD J Director Sell 47.5 -3,500 -0.83% ✓ $122.9K
Jul 20, 2021 Jul 22, 2021 Mack David Henry CEO Sell 26.3 -27,796 -8.23% ✓ $993.7K